A case of idiopathic pulmonary fibrosis treated with clarithromycin

ISSN: 1301-0883
Başlangıç: 1996
Yayıncı: ERBİL KARAMAN

We report a case of idiopathic pulmonary fibrosis (IPF) treated successfully using clarithromycin (CAM). A 64-year-old male patient suffering from IPF which had been diagnosed at 59 years old, presented with slowly progressive dyspnea. Until this time, his condition had been almost stable. He was diagnosed with exacerbation of IPF, based on exacerbation of lung ausculation, O2 saturation by pulse oxymetry, Krebs von den Lungen 6 levels and chest computed tomography findings of reticular opacities. He was successfully treated using CAM in expectation of its anti-inflammatory effects. This case shows that treatment using CAM may be effective in some cases of IPF.

PDF

___

References 1. Taniguchi H, Ebina M, Kondoh Y, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir 2010; 35: 821-829.

2. Kim YH and Kwon SS. Interstitial lung diseases: Respiratory reviews of 2013. Tuberc Respir Dis 2013; 75: 47-51.

3. Jouneau S, Kerjouan M, Caulet-Maugendre S, et al. Clarithromycin stops lung function decline in airway-centered interstitial fibrosis. Respiration 2013; 85: 156-159.

4. Kohno N. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest 1999; 46: 151-158.

5. Hügle T. Immunology of fibrotic lung disease: managing infections whilst preventing autoimmunity? J Inflam Res 2011; 4: 21-27.

6. Chen B, Jiang L, Zhao W, Yu R, Hou XM. Ameliorating effect of erythromycin on bleomycin-induced pulmonary fibrosis: role of alveolar macrophage activation and cytokine release. Respoil 1997; 2: 151-155.